Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.04 USD | +4.39% | +17.44% | -5.39% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 212M |
---|---|---|---|---|---|
Net income 2024 * | -140M | Net income 2025 * | -159M | EV / Sales 2024 * | - |
Net cash position 2024 * | 207M | Net cash position 2025 * | 161M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-2.05
x | Employees | 128 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.07% |
Latest transcript on Prelude Therapeutics Incorporated
1 day | +4.39% | ||
1 week | +17.44% | ||
Current month | -14.77% | ||
1 month | -12.36% | ||
3 months | +20.96% | ||
6 months | +95.17% | ||
Current year | -5.39% |
Managers | Title | Age | Since |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 16-01-31 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 23-01-31 |
Jane Huang
PSD | President | 51 | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 21-01-24 |
Paul Friedman
CHM | Chairman | 81 | 16-06-30 |
David Bonita
BRD | Director/Board Member | 48 | 16-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.04 | +4.39% | 115 098 |
24-04-24 | 3.87 | 0.00% | 28,584 |
24-04-23 | 3.87 | +0.52% | 24,900 |
24-04-22 | 3.85 | +3.49% | 50,051 |
24-04-19 | 3.72 | +8.14% | 57,910 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.39% | 212M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- PRLD Stock